Fact CheckerSign in

NCT07066670Completed

Strain Counterstrain and Muscle Energy Technique in Patients of Knee Osteoarthritis

Comparative Effects of Strain Counterstrain and Muscle Energy Technique on Pain, Range of Motion, and Functional Disability in Patients of Knee Osteoarthritis

Source: ClinicalTrials.gov · Last updated 15 Jul 2025

Brief summary (registry, in English)

This study aimed to evaluate the comparative effects of Strain Counterstrain (SCS) and Muscle Energy Technique (MET) on pain, range of motion (ROM), and functional disability in patients with knee osteoarthritis (KOA). Conducted as a single-blinded randomized control trial at the University of Lahore Teaching Hospital, 76 participants were divided into two groups, receiving either SCS or MET alongside routine physical therapy. Outcome measures included pain intensity, ROM, and functional disability via KOOS.

Status (registry)
Completed
Study type
Interventional
Enrollment
76 (actual)
First submitted
3 Apr 2025
Start date
15 Mar 2024
Primary completion date
13 Dec 2024
Lead sponsor
University of Lahore
Diseases
Stroke
NCT number
NCT07066670

What you commit to

  • Study type: Interventional
  • Participants enrolled: 76
  • From 15 Mar 2024 to the primary completion date, 13 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients having any previous knee surgery (Khan et al., 2023).

Other illness

  • Having any tumor or related pathology such as cancer (Arslan et al., 2022).
  • Patients with isolated/predominantly patellofemoral symptomatic osteoarthritis, inflammatory diseases, joint effusion, or excessive knee deformity (Deng et al., 2021).

Other

  • Congenital deformities (Deng et al., 2021).

Who the study is looking for

  • Age between 45 to 65 years (Pandiselvi, 2019).
  • Patients who were willing and able to comply with the study protocol and follow-up procedures (Arslan et al., 2022).
  • Patients having Grade 2 knee OA Kellgren and Lawrence system. In this system, grade 2 signifies minimal severity of OA (Ratzlaff et al., 2018).

Age in the registry: 45 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The University of Lahore Teaching Hospital
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.